Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Leiden Center for Applied Bioscience, University of Applied Sciences Leiden, Leiden, The Netherlands.
PLoS One. 2020 Jun 25;15(6):e0235093. doi: 10.1371/journal.pone.0235093. eCollection 2020.
Bacterial biofilms are one of the major issues in the treatment of chronic infections such as chronic wounds, where biofilms are typically polymicrobial. The synergy between species can occur during most polymicrobial infections, where antimicrobial resistance enhances as a result. Furthermore, self-produced extracellular polymeric substance (EPS) in biofilms results in a high tolerance to antibiotics that complicates wound healing. Since most antibiotics fail to remove biofilms in chronic infections, new therapeutic modalities may be required. Disruption of EPS is one of the effective approaches for biofilm eradication. Therefore, degradation of EPS using enzymes may result in improved chronic wounds healing. In the current study, we investigated the efficacy of trypsin, β-glucosidase, and DNase I enzymes on the degradation of dual-species biofilms of Pseudomonas aeruginosa and Staphylococcus aureus in a wound-like medium. These species are the two most common bacteria associated with biofilm formation in chronic wounds. Moreover, the reduction of minimum biofilm eradication concentration (MBEC) of meropenem and amikacin was evaluated when combined with enzymes. The minimum effective concentrations of trypsin, β-glucosidase, and DNase I enzymes to degrade biofilms were 1 μg/ml, 8 U/ml, and 150 U/ml, respectively. Combination of 0.15 μg/ml trypsin and 50 U/ml DNase I had a significant effect on S. aureus-P. aeruginosa biofilms which resulted in the dispersal and dissolution of all biofilms. In the presence of the enzymatic mixture, MBECs of antibiotics showed a significant decrease (p < 0.05), at least 2.5 fold. We found that trypsin/DNase I mixture can be used as an anti-biofilm agent against dual-species biofilms of S. aureus-P. aeruginosa.
细菌生物膜是治疗慢性感染(如慢性伤口)的主要问题之一,生物膜通常是多微生物的。在大多数多微生物感染中,物种之间会产生协同作用,从而导致抗生素耐药性增强。此外,生物膜中自产生的细胞外聚合物(EPS)导致对抗生素产生高度耐受性,从而使伤口愈合复杂化。由于大多数抗生素无法清除慢性感染中的生物膜,可能需要新的治疗方法。破坏 EPS 是生物膜根除的有效方法之一。因此,使用酶降解 EPS 可能会导致慢性伤口愈合得到改善。在本研究中,我们研究了胰蛋白酶、β-葡糖苷酶和 DNA 酶 I 酶在类似于伤口的培养基中对铜绿假单胞菌和金黄色葡萄球菌双物种生物膜的降解作用。这两种物种是与慢性伤口生物膜形成相关的两种最常见的细菌。此外,还评估了与酶组合使用时,美罗培南和阿米卡星的最低生物膜根除浓度(MBEC)降低情况。降解生物膜的胰蛋白酶、β-葡糖苷酶和 DNA 酶 I 酶的最小有效浓度分别为 1μg/ml、8U/ml 和 150U/ml。0.15μg/ml 胰蛋白酶和 50U/ml DNA 酶 I 的组合对金黄色葡萄球菌-铜绿假单胞菌生物膜有显著影响,导致所有生物膜的分散和溶解。在酶混合物存在的情况下,抗生素的 MBEC 显示出明显下降(p<0.05),至少降低了 2.5 倍。我们发现胰蛋白酶/DNA 酶 I 混合物可用作针对金黄色葡萄球菌-铜绿假单胞菌双物种生物膜的抗生物膜剂。